Table 2 summarizes the results of the primary analyses of 12-month remission (COGA) and remission (Indiana Biobank) as the outcomes using the GEE and logistic regression models. In COGA, increasing PGSAUD was negatively associated with remission in EA but was not associated in AA. In both EA and AA, female sex, AUD duration, and both treatments were associated with increased probability of 12-month remission, and older age with decreased probability of remission. In EA only, family history of remission, mutual help only, and utilizing both mutual help and professional treatments were associated with increased probability of 12-month remission. COGA results for abstinent and non-abstinent remission outcomes are presented in Table 3. PGSAUD were associated with decreased probability of non-abstinent remission in EA but had no association with EA abstinent remission or AA non-abstinent or abstinent remission. Family history of remission was associated with increased likelihood of remission in EA and AA abstinent and non-abstinent subgroups. Except for professional treatment only in EA and the non-abstinent subgroup in AA, all other treatments were associated with remission.
